Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignant hypertension and interferon-beta: a case report.

× No keyword cloud information.

9 in total

1. Hypertensive crisis: forget the numbers.

Authors: Eduardo Pimenta; David A Calhoun
Journal: J Hypertens Date: 2012-05 Impact factor: 4.844

2. Long-term renal survival in malignant hypertension.

Authors: Roberto González; Enrique Morales; Julian Segura; Luis M Ruilope; Manuel Praga
Journal: Nephrol Dial Transplant Date: 2010-03-17 Impact factor: 5.992

3. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.

Authors: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal: Am J Hypertens Date: 2010-08-19 Impact factor: 2.689

4. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.

Authors: Bert-Jan H van den Born; Richard P Koopmans; Gert A van Montfrans
Journal: Am J Hypertens Date: 2007-08 Impact factor: 2.689

5. Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.

Authors: Corentin Orvain; Jean-François Augusto; Virginie Besson; Guillaume Marc; Paul Coppo; Jean-François Subra; Johnny Sayegh
Journal: Int Urol Nephrol Date: 2013-02-24 Impact factor: 2.370

6. Impact of malignant arterial hypertension on the heart.

Authors: Philippe Gosse; Paul Coulon; Georgios Papaioannou; Jean Litalien; Philippe Lemetayer
Journal: J Hypertens Date: 2011-04 Impact factor: 4.844

7. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.

Authors: J D Blumenfeld; J E Sealey; S J Mann; A Bragat; R Marion; M S Pecker; J Sotelo; P August; T G Pickering; J H Laragh
Journal: Am J Hypertens Date: 1999-05 Impact factor: 2.689

8. Thrombotic microangiopathy associated with use of interferon-beta.

Authors: Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal: Int J Nephrol Renovasc Dis Date: 2012-06-15

9. Renal thrombotic microangiopathy induced by β-interferon.

Authors: Gioacchino Li Cavoli; Luisa Bono; Calogera Tortorici; Carlo Giammarresi; Ugo Rotolo
Journal: NDT Plus Date: 2010-11-19

9 in total

3 in total

1. Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.

Authors: David Kavanagh; Sarah McGlasson; Alexa Jury; Jac Williams; Neil Scolding; Chris Bellamy; Claudia Gunther; Diane Ritchie; Daniel P Gale; Yashpal S Kanwar; Rachel Challis; Holly Buist; James Overell; Belinda Weller; Oliver Flossmann; Mark Blunden; Eric P Meyer; Thomas Krucker; Stephen J W Evans; Iain L Campbell; Andrew P Jackson; Siddharthan Chandran; David P J Hunt
Journal: Blood Date: 2016-09-23 Impact factor: 25.476

2. A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review.

Authors: Mosè Parisi; Alessia Manni; Francesca Caputo; Maria Trojano; Damiano Paolicelli
Journal: Brain Behav Date: 2020-12-16 Impact factor: 2.708

3. Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.

Authors: Marco Allinovi; Calogero Lino Cirami; Leonardo Caroti; Giulia Antognoli; Silvia Farsetti; Maria Pia Amato; Enrico Eugenio Minetti
Journal: Clin Kidney J Date: 2017-02-16

3 in total